Exodus Point Capital Management, LP Neurocrine Biosciences Inc Transaction History

Exodus Point Capital Management, LP

$16.4 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$130.86 - $143.19 $3.15 Million - $3.44 Million	-24,050 Reduced 64.38%	13,304 $1.83 Million
Q1 2024 May 14, 2024	BUY	$130.4 - $143.74 $725,806 - $800,056	5,566 Added 17.51%	37,354 $5.15 Million
Q3 2023 Nov 09, 2023	SELL	$94.02 - $117.1 $7.98 Million - $9.94 Million	-84,917 Reduced 72.76%	31,788 $3.58 Million
Q2 2023 Aug 10, 2023	SELL	$89.53 - $104.87 $5.13 Million - $6.01 Million	-57,295 Reduced 32.93%	116,705 $11 Million
Q1 2023 May 11, 2023	BUY	$94.11 - $123.02 $9.5 Million - $12.4 Million	100,994 Added 138.34%	174,000 $17.6 Million
Q4 2022 Feb 13, 2023	BUY	$106.72 - $127.06 $2.35 Million - $2.8 Million	22,025 Added 43.2%	73,006 $8.72 Million
Q3 2022 Nov 10, 2022	SELL	$92.03 - $107.81 $1.12 Million - $1.32 Million	-12,207 Reduced 19.32%	50,981 $5.42 Million
Q2 2022 Aug 19, 2022	BUY	$75.79 - $100.07 $1.22 Million - $1.61 Million	16,066 Added 34.09%	63,188 $6.16 Million
Q1 2022 May 13, 2022	SELL	$72.45 - $94.81 $1.42 Million - $1.86 Million	-19,618 Reduced 29.39%	47,122 $4.42 Million
Q4 2021 Feb 11, 2022	BUY	$79.65 - $106.22 $3.26 Million - $4.34 Million	40,867 Added 157.95%	66,740 $5.68 Million
Q3 2021 Nov 15, 2021	SELL	$86.18 - $99.03 $2.54 Million - $2.92 Million	-29,521 Reduced 53.29%	25,873 $2.48 Million
Q2 2021 Aug 16, 2021	BUY	$89.43 - $102.27 $4.95 Million - $5.67 Million	55,394 New	55,394 $5.39 Million
Q1 2021 May 17, 2021	SELL	$87.57 - $119.4 $611,501 - $833,770	-6,983 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$86.91 - $108.33 $1.03 Million - $1.28 Million	-11,840 Reduced 62.9%	6,983 $669,000
Q3 2020 Nov 16, 2020	SELL	$96.16 - $135.15 $707,064 - $993,757	-7,353 Reduced 28.09%	18,823 $1.81 Million
Q2 2020 Aug 14, 2020	SELL	$85.09 - $130.36 $247,867 - $379,738	-2,913 Reduced 10.01%	26,176 $3.19 Million
Q1 2020 May 15, 2020	BUY	$75.11 - $113.76 $2.18 Million - $3.31 Million	29,089 New	29,089 $2.52 Million
Q4 2019 Feb 14, 2020	SELL	$86.8 - $118.57 $3.88 Million - $5.31 Million	-44,746 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$83.82 - $101.5 $578,944 - $701,060	6,907 Added 18.25%	44,746 $4.03 Million
Q2 2019 Aug 14, 2019	SELL	$72.24 - $91.27 $1.03 Million - $1.3 Million	-14,219 Reduced 27.31%	37,839 $3.2 Million
Q1 2019 May 15, 2019	BUY	$69.31 - $91.53 $2.58 Million - $3.41 Million	37,225 Added 250.96%	52,058 $4.59 Million
Q4 2018 Feb 14, 2019	BUY	$68.32 - $124.36 $1.01 Million - $1.84 Million	14,833 New	14,833 $1.06 Million

Others Institutions Holding NBIX

# of Institutions

626

Shares Held

94M

Call Options Held

632K

Put Options Held

621K

Black Rock Inc. New York, NY

14.2M
Shares

$1.92 Billion
0.04% of portfolio
Vanguard Group Inc Valley Forge, PA

10M
Shares

$1.35 Billion
0.02% of portfolio
State Street Corp Boston, MA

5.15M
Shares

$697 Million
0.02% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

2.57M
Shares

$349 Million
0.47% of portfolio
Bellevue Group Ag Kuesnacht, V8

1.86M
Shares

$252 Million
3.62% of portfolio

View Full List

About NEUROCRINE BIOSCIENCES INC

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $13B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

More about NBIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Exodus Point Capital Management, LP with notifications on news.

Account